Berirab 2 ml, Injektionslösung - Spritze(n) à 2 ml Swissmedic Key 00687003 Registration Holder CSL Behring AG Name Berirab 2 ml, Injektionslösung Date of registration 05.05.2004 Introduction of Sequence 05.05.2004 ATC-Classification Rabies Immunoglobulin (J06BB05) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size Spritze(n) à 2 ml Index Therapeuticus (Swissmedic) 08.09. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680006870031 Medication Code Blutprodukte Pharmacode Disponibility
Composition immunoglobulinum humanum anti-rabies 300 U.I. corresp. immunoglobulina 200-340 mg, glycinum, natrii chloridum, aqua q.s. ad solutionem pro 2 ml. Packungsbestandteile Galenic Form Injection solution Excipiens Active Agent Dose Immunoglobulinum Humanum Anti-Rabies 300U.I. / 2ml correspond Immunoglobulina 270mg / 2ml
Inactive agents Glycin Sodium Chloride
Source Data was imported : 06.12.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
